689P Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)
Abstract
Predictive biomarkers for IO in m-ccRCC are lacking. As antigen presentation by HLA class I/II is essential for T cell activation, impact of tumoral HLA expression on IO efficacy was studied in one French (NIVOREN GETUG-AFU 26) and two Belgian patient (pt)...
Paper Details
Title
689P Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)
Published Date
Sep 1, 2021
Journal
Volume
32
Pages
S706 - S706
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History